Volume 15 - Articles-1404                   MEJDS (2025) 15: 77 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rasouli Azad S, Lotfi Kashani F, Vaziri S. Determining the Effectiveness of Cognitive-Behavioral Therapy on Illness-Related Worry and Fear of Recurrence in Women Recovered from Breast Cancer. MEJDS 2025; 15 (0) :77-77
URL: http://jdisabilstud.org/article-1-3590-en.html
1- PhD Student, Department of Health Psychology, Roudehen Branch, Islamic Azad University, Roudehen, Iran
2- Associate Professor, Department of Clinical Psychology, Tehran Medical Sciences Unit, Islamic Azad University, Tehran, Iran
Abstract:   (534 Views)

Abstract
Background & Objectives: Breast cancer, as the most common cancer in women, can cause serious psychological complications such as anxiety and depression. This disease requires attention to the mental health of patients, especially after treatment. Cognitive-behavioral therapy is recognized as an effective approach for managing these psychological problems and can help reduce worries, thereby improving the quality of life for patients. Ultimately, research in this field helps to understand the psychological needs of these patients better and provides effective support solutions. As an effective approach to managing psychological problems, cognitive-behavioral therapy has positive effects on fear of cancer recurrence, body image, and disease-related concerns. This therapy helps patients recognize and change their negative and irrational thought patterns. These patterns may include thoughts about the disease recurring or a feeling of lack of control over their health. By changing these thoughts, patients can reduce their fears. So, the present study aimed to determine the effectiveness of cognitive-behavioral therapy on worry about the disease and fear of recurrence in women recovered from breast cancer.
Methods: The present study employed a quasi-experimental design with a pretest-posttest approach, including both control and experimental groups. The statistical population included adult women who referred to hospitals in Tehran City, Iran, for annual check-ups in 2024 and received a diagnosis of recovery from breast cancer from a specialist physician within the past 1 to 4 years. Thirty women were selected using available sampling and randomly assigned to an experimental group (n = 15) and a control group (n = 15). The inclusion criteria included no history of psychiatric disorders based on case records, an average age of over 20 years and a minimum education of a high school diploma, recovery from breast cancer between 1 and 4 years before the start of the study, no drug therapy or other psychological treatment at the time of diagnosis, and informed and voluntary consent to participate in the study. The exclusion criteria for the study also included the absence of more than three sessions, unexpected incidents such as serious physical injuries that may occur during the study, and lack of full cooperation in the study, including failure to complete the questionnaires correctly and accurately, as well as their distortion. The implementation process was as follows: after selecting the sample group and before starting the treatment program, the Penn State Worry Questionnaire (PSWQ) (Meyer et al., 1990) and the Fear of Cancer Recurrence Inventory (FCRI) (Simard & Savard, 2009) were distributed to both groups. After that, cognitive behavioral therapy was implemented on the experimental group (in the form of eight 90-minute sessions, each session once a week), and the control group was not subjected to any treatment program. After the sessions concluded, participants from both groups completed the questionnaires mentioned above again. The data from the study were analyzed using SPSS version 27 software and multivariate analysis of covariance at a significance level of 0.05.
Results: After controlling for the pretest effect, the results showed a significant difference between the posttest scores of the experimental and control groups in worry about illness and fear of recurrence (triggers, confusion, dysfunction, insight, confidence, and coping in interaction) (p<0.001).
Conclusion: According to the research results, cognitive-behavioral therapy helps women who have recovered from breast cancer feel more in control of their condition and effectively manage worry about the disease and fear of recurrence by changing negative thought patterns, increasing coping skills, and strengthening social support.

Full-Text [PDF 292 kb]   (123 Downloads)    
Type of Study: Original Research Article | Subject: Psychology

References
1. Jiang H, Dong Y, Zong W, Zhang X jie, Xu H, Jin F. The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy. BMC Womens Health. 2022;22(1):135. [DOI]
2. Afaya A, Japiong M, Konlan KD, Salia SM. Factors associated with awareness of breast cancer among women of reproductive age in Lesotho: a national population-based cross-sectional survey. BMC Public Health. 2023;23(1):621. [DOI]
3. Ariyanti R, Yulianti I. Special needs of women’s psychological problems during unwanted pregnancy with hypnotherapy. Jurnal Kesehatan Mahardika. 2022;9(1):23–7. [DOI]
4. Zhu JW, Charkhchi P, Adekunte S, Akbari MR. What is known about breast cancer in young women? Cancers. 2023;15(6):1917. [DOI]
5. Luo L, Wang X, Lin Y, Ma X, Tan A, Chan R, et al. Deep learning in breast cancer imaging: a decade of progress and future directions. IEEE Rev Biomed Eng. 2025;18:130–51. [DOI]
6. Maheu C, Lebel S, Bernstein LJ, Courbasson C, Singh M, Ferguson SE, et al. Fear of cancer recurrence therapy (FORT): a randomized controlled trial. Health Psychol. 2023;42(3):182–94. [DOI]
7. Carreira H, Williams R, Funston G, Stanway S, Bhaskaran K. Associations between breast cancer survivorship and adverse mental health outcomes: a matched population-based cohort study in the United Kingdom. PLoS Med. 2021;18(1):e1003504. [DOI]
8. Alwhaibi M, AlRuthia Y, Sales I. The impact of depression and anxiety on adult cancer patients’ health-related quality of life. J Clin Med. 2023;12(6):2196. [DOI]
9. Pu D, Xu D, Wu Y, Chen H, Shi G, Feng D, et al. Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella review. J Cancer Res Clin Oncol. 2024;150(1):16. [DOI]
10. Obeagu EI, Obeagu GU. Breast cancer: a review of risk factors and diagnosis. Medicine. 2024;103(3):e36905. [DOI]
11. Li ZH, Yang GH, Wang F. Molecular mechanisms of Baihedihuang decoction as a treatment for breast cancer related anxiety: a network pharmacology and molecular docking study. World J Clin Cases. 2022;10(33):12104–15. [DOI]
12. Wu H, Aziz AR, Dehghan M, Ahmadi Lari L, Al-Amer R, Zakeri MA. Use of complementary and alternative medicine for reducing fear of cancer recurrence among cancer survivors: does it work? Asia Pac J Oncol Nurs. 2023;10(10):100278. [DOI]
13. Webb K, Sharpe L, Russell H, Shaw J. Fear of cancer recurrence in ovarian cancer caregivers: a qualitative study. Psychooncology. 2024;33(1):e6255. [DOI]
14. Sheng L, Zhu Y, Liu Y, Hua H, Zhou J, Ye L. Fear of cancer recurrence and associated factors in family caregivers of patients with hematologic malignancy receiving chemotherapy: a latent profile analysis. Asia Pac J Oncol Nurs. 2024;11(4):100382. [DOI]
15. Cincidda C, Pizzoli SFM, Pravettoni G. Remote psychological interventions for fear of cancer recurrence: scoping review. JMIR Cancer. 2022;8(1):e29745. [DOI]
16. Burkholder MP. Cognitive behavioral therapy. In: Sowers WE, McQuistion HL, Ranz JM, Feldman JM, Runnels PS; editors. Textbook of community psychiatry. Cham: Springer International Publishing; 2022. [DOI]
17. Altena E, Ellis J, Camart N, Guichard K, Bastien C. Mechanisms of cognitive behavioural therapy for insomnia. J Sleep Res. 2023;32(6):e13860. [DOI]
18. Aricò D, Raggi A, Ferri R. Cognitive behavioral therapy for insomnia in breast cancer survivors: a review of the literature. Front Psychol. 2016;7. [DOI]
19. Getu MA, Chen C, Panpan W, Mboineki JF, Dhakal K, Du R. The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res. 2021;30(2):367–84. [DOI]
20. Moorthy A, Lowry D, Edgley C, Casey MB, Buggy D. Effect of perioperative cognitive behavioural therapy on chronic post-surgical pain among breast cancer patients with high pain catastrophising characteristics: protocol for a double-blinded randomised controlled trial. Trials. 2022;23(1):66. [DOI]
21. Hooman HA. Understanding the scientific method in behavioral sciences. Tehran: Samt Publications; 2014. [Persian]
22. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of The Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487–95. [DOI]
23. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51. [DOI]
24. Dehshiri GhR, Golzari M, Borjali A, Sohrabi F. Psychometrics particularity of Farsi version of Pennsylvania State Worry Questionnaire for college students. Journal of Clinical Psychology. 2010;1(4):67–75. [Persian] [Article]
25. Bateni FS, Rahmatian M, Kaviani A, Simard S, Soleimani M, Nejatisafa AA. The Persian version of the Fear of Cancer Recurrence Inventory (FCRI): translation and evaluation of its psychometric properties. Arch Breast Cancer. 2019;6(4):174–80. [DOI]
26. Salkovskis H, Clark K. Cognitive behavior therapy for psychiatric problems: a practical guide volume II. Ghasemzadeh, H. (Persian translator). Arjomand Pub; 2017.
27. Sajadian A, Zahrakar K, Asadpour E. Effectiveness of transpersonal therapy (spiritual therapy, yoga-meditation) in reducing fear of cancer recurrence in breast cancer survivors: a randomized controlled trial. Iranian Quarterly Journal of Breast Diseases. 2021;14(2):50–63. [Persian] [DOI]
28. Zanganeh Gheshlaghi M, Shayegan Manesh Z, Bankdari N. The effectiveness of cognitive behavioral therapy on depression and anxiety in women with breast cancer. Medical Journal of Mashad University of Medical Sciences. 2021;63(5):2967–74. [Persian] [Article]
29. Ciążyńska M, Płużańska-Srebrzyńska K, Narbutt J, Kolano P, Stasikowska-Kanicka O, Lesiak A. Scalp metastases as the first sign of a breast carcinoma. Postepy Dermatol Allergol. 2021;38(3):530–2. [DOI]
30. Lin C, Tian H, Chen L, Yang Q, Wu J, Ji Z, et al. The efficacy of cognitive behavioral therapy for cancer: a scientometric analysis. Front Psychiatry. 2022;13:1030630. [DOI]
31. Starling CM, Greenberg D, Zhou E, Lewin D, Morrow AS, Lieberman D, et al. Testing delivery of components of cognitive behavioral therapy for insomnia to breast cancer survivors by smart speaker: a study protocol. BMC Med Inform Decis Mak. 2022;22(1):163. [DOI]
32. Robles TF, Slatcher RB, Trombello JM, McGinn MM. Marital quality and health: a meta-analytic review. Psychol Bull. 2014;140(1):140–87. [DOI]
33. Park SY, Lim JW. Cognitive behavioral therapy for reducing fear of cancer recurrence (FCR) among breast cancer survivors: a systematic review of the literature. BMC Cancer. 2022;22(1):217. [DOI]
34. Emami M, Askarizadeh GH, Faziltzpour M. Effectiveness of cognitive behavioral stress management group therapy on resilience and hope in women with breast cancer. Journal of Positive Psychology Research. 2017;3(4):1–14. [Persian]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Middle Eastern Journal of Disability Studies

Designed & Developed by : Yektaweb